Trial Profile
Bilastine and Montelukast in Patients With Seasonal Allergic Rhinoconjunctivitis and Asthma: Efficacy of Concomitant Administration - the SKY Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Bilastine (Primary) ; Montelukast (Primary)
- Indications Allergic rhinoconjunctivitis; Asthma; Seasonal allergic rhinitis
- Focus Therapeutic Use
- Acronyms SKY
- Sponsors Menarini
- 13 Jun 2019 This trial has been completed Czech Republic, Latvia, and Slovakia (end date: 2016-11-23)
- 16 Jan 2017 Status changed from active, no longer recruiting to completed.
- 13 Dec 2016 This trial has been completed Poland (end date: 2016-11-23)